Peripheral Arterial Disease Market Report Provides Insights Into Market Evolution And Growth Prospects

The peripheral arterial disease (PAD) market is gearing up for substantial growth as advancements in medical technology and patient care continue to evolve. With increasing awareness and innovative treatment options, the industry is expected to undergo significant expansion over the coming years. Below, we explore the market size projections, leading companies, emerging trends, and key segments shaping this dynamic healthcare sector.

Peripheral Arterial Disease Market Size and Growth Outlook by 2030
The market for peripheral arterial disease is projected to experience robust growth, reaching a valuation of $7.28 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 9.2%. Several factors contribute to this upward trajectory, including improvements in minimally invasive endovascular techniques, wider adoption of drug-eluting devices, and the ongoing establishment of specialized hospitals and clinics focusing on PAD treatment. Additionally, heightened patient awareness about the importance of early diagnosis and intervention, combined with the growing use of combination therapies involving lifestyle changes and medication, is driving market demand. Key trends anticipated during this period include the increased implementation of artificial intelligence for early detection and risk evaluation, the rise of digital and cloud-based patient monitoring platforms, a stronger focus on personalized PAD therapies based on genomic data, incorporation of Internet of Things (IoT) devices for post-treatment surveillance, and advanced manufacturing methods enhanced by smart technologies.

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4.74 billion in 2025 to $5.12 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to high prevalence of peripheral arterial disease, limited awareness of PAD symptoms, reliance on conventional medications, inadequate access to vascular specialists, fragmented care delivery systems.

Download a free sample of the peripheral arterial disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Leading the Peripheral Arterial Disease Market
Several prominent players dominate the PAD market landscape, such as Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton dic*kinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, and Contego Medical LLC.
In a notable development, Abbott Laboratories, a US pharmaceutical giant, acquired Cardiovascular Systems Inc. in February 2023 for $890 million. This strategic acquisition aims to bolster Abbott's cardiovascular portfolio by integrating complementary technologies from Cardiovascular Systems Inc., a company specialized in medical devices for peripheral and coronary vascular disease treatments.

Emerging Innovations Shaping the Peripheral Arterial Disease Market
Industry leaders are driving innovation by focusing on next-generation medical devices that enhance treatment effectiveness, patient recovery, and overall outcomes for vascular conditions. A prime example is the intravascular lithotripsy (IVL) catheter, a device designed to treat calcified arterial blockages by using controlled shockwaves to fragment calcium deposits. This method helps restore blood flow and improves the flexibility of blood vessels during procedures like angioplasty. For instance, in September 2024, Shockwave Medical, a US-based medical technology company, introduced its Shockwave E8 peripheral IVL catheter. This device uses sonic waves to carefully break down calcium build-ups in arterial walls while minimizing damage to surrounding tissues. Its advanced structure also facilitates easier navigation through complex blood vessel networks, making it suitable for a broad patient population.

View the full peripheral arterial disease market report:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Core Segments Contributing to Peripheral Arterial Disease Market Expansion
The peripheral arterial disease market is segmented into several key categories:
1) Treatment Type: including Devices, Catheters, Drugs, and Other Types
2) Route of Administration: covering Oral, Parenteral, and Other administration methods
3) End User: encompassing Hospitals, Specialty Clinics, and other healthcare providers
Further breakdown within these segments includes:
- Devices: Stents, Balloons, Atherectomy Devices
- Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires
- Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators
- Other Types: Surgical interventions, Lifestyle modification programs, and Endovascular therapy
This detailed segmentation supports a comprehensive understanding of the market dynamics and assists stakeholders in identifying opportunities throughout the PAD treatment landscape.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.